Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 237

    Article Cited by others

REVIEW ARTICLE

Clinical use of insulin degludec: Practical experience and pragmatic suggestions

Kalra Sanjay, Gupta Yashdeep

Year : 2015| Volume: 7| Issue : 3 | Page no: 81-85

   This article has been cited by
 
1 Practical Guidance on Basal Insulin Initiation and Titration in Asia: A Delphi-Based Consensus
Siew Pheng Chan, Azizul Hasan Aamir, Yong Mong Bee, Chaicharn Deerochanawong, Elizabeth Paz-Pacheco, Fatma Tiu, Siew Hui Foo, Kevin E. K. Tan, Toan Q. Le, Made Ratna Saraswati, Pongamorn Bunnag, Roy Panusunan Sibarani, Syed Abbas Raza, Nam Quang Tran
Diabetes Therapy. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Comparing time to intensification between insulin degludec/insulin aspart and insulin glargine: A single-center experience from India
Rajiv Kovil
Journal of Diabetology. 2022; 13(2): 171
[Pubmed]  [Google Scholar] [DOI]
3 Simultaneous quantitative determination of liraglutide and insulin degludec in rat plasma by liquid chromatography–tandem mass spectrometry method and its application
Jianping Zhai,Li Li,Lihou Dong,Kelly Dong,Shensi Xiang,Luolan Gui,Jiaying Zhang,Haifeng Song,Zhiqiang Ge
Biomedical Chromatography. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Insulin: a review of analytical methods
Yixiao Shen,Witoon Prinyawiwatkul,Zhimin Xu
The Analyst. 2019;
[Pubmed]  [Google Scholar] [DOI]
5 Perioperative insulin therapy
Prangmalee Leurcharusmee,Guy Kositratna,De Q. Tran,Thomas Schricker
Asian Biomedicine. 2018; 11(5): 395
[Pubmed]  [Google Scholar] [DOI]
6 Switching basal insulins in type 2 diabetes: practical recommendations for health care providers
Sarah L. Anderson,Jennifer M. Trujillo,John E. Anderson,Robert J. Tanenberg
Postgraduate Medicine. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
7 Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer’s Disease
Suzanne M. de la Monte
Drugs. 2017; 77(1): 47
[Pubmed]  [Google Scholar] [DOI]
8 Comment on “Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis”
Sanjay Kalra
Primary Care Diabetes. 2016;
[Pubmed]  [Google Scholar] [DOI]
9 Improvements in symptomatic treatment strategies for cystic fibrosis: delivering CF care in the 21st century
Charlotte Addy,Damian G Downey,J Stuart Elborn
Expert Opinion on Orphan Drugs. 2016; 4(1): 5
[Pubmed]  [Google Scholar] [DOI]

 

Read this article